| [ X ] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|-----------------|-----------------------------------------------------------------------------------------|

| CALIFORNIA                                 | 333-29295                         | 95-4298051                    |
|------------------------------------------------------|-----------------------------------|-------------------------------|
| (State of incorporation or organization)   | (Commission File No.)   | (I.R.S. Identification Number |

|                                                                              |
|-----------------------------------------------------------------------------------|
| Former name, former address, and former fiscal year, if changed since last report |

| Large accelerated filer  [_]                                                        |   | Accelerated filer  [_]         |
|-------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------|
| Non-accelerated filer   [_] (Do not check if a smaller reporting company)      |   | Smaller reporting company  [X] |

----

|                           |  Page                                                                                                                                                             |
|--------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Part I - FINANCIAL INFORMATION |                                                                                                                                                                   |  |   |
| Item 1.                        | Financial Statements                                                                                                                                                   |   |  |   |
|                           | Balance Sheets as of March 31, 2016 (unaudited) and December 31, 2015 (unaudited)                                                                                 |   |   | 2 |   |
|                                | Statements of Operations (unaudited) for the Three months ended March 31, 2016 and 2015, and for the Development Period from October 11, 2006 to March 31, 2016.  |   |  | 4 |   |
|                           | Statements of Cash Flows (unaudited) for the three months ended March 31, 2016 and 2015, and for the Development Period from October 11, 2006 to March 31, 2016   |   |   | 5 |   |
|                           | Notes to Financial Statements (unaudited)                                                                                                                              |   |   | 6 |   |
| Item 2.                        | Management's Discussion and Analysis or Plan of Operation                                                                                                              |   |   | 10 |   |
| Item 3.                        | Quantitative and Qualitative Disclosures About Market Risk                                                                                                             |   |   | 11 |   |
| Item 4.                        | Controls and Procedures                                                                                                                                                |   |   | 11 |   |
|                           |                                                                                                                                                                   |   |   |   |   |
| Part II - OTHER INFORMATION    |                                                                                                                                                                   |   |   |   |
| Item 1.                        | Legal Proceedings                                                                                                                                                      |   |   | 12 |   |
| Item 1A.                       | Risk Factors                                                                                                                                                           |   |   | 12 |   |
| Item 2.                        | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                            |   |   | 12 |   |
| Item 3.                        | Defaults Upon Senior Securities                                                                                                                                        |   |   | 12 |   |
| Item 4.                        | Mine Safety Disclosures                                                                                                                                                |   |   | 12 |   |
| Item 5.                        | Other Information                                                                                                                                                      |   |   | 12 |   |
| Item 6.                        | Exhibits                                                                                                                                                               |   |   | 12 |   |
| SIGNATURES                     |                                                                                                                                                                   |   | 13 |   |

----

|                                                    |   | March 31, 2016 |       |   | December 31, 2015 |   |
|--------------------------------------------------------------|--------|----------------|------------|--------|-------------------|--------|
|                                                    |   | (Unaudited)    |       |   | (Unaudited)       |   |
| ASSETS                                                       |   |                |       |   |                   |   |
|                                                         |   |                |       |   |                   |   |
| Current assets:                                              |   |                |       |   |                   |   |
|  Cash                                                   |   |                |       |   |              | 0      |   |
| Total current assets                                         |   | $              | -          |   |              | $      | - |   |
|                                                         |   |           |       |   |              |   |   |   |
|                                                         |   |           |       |   |              |   |   |   |
|                                                         |   |           |       |   |              |   |   |   |
|                                                         |   |           |       |   |              |   |   |   |
| LIABILITIES AND STOCKHOLDERS' (DEFICIT)                      |   |           |       |   |              |   |   |   |
|                                                         |   |           |       |   |              |   |   |   |
| Current liabilities:                                         |   |           |       |   |              |   |   |   |
| Accounts payable                                             |   | $              | 2,731      |   |              | $      | 3,904 |   |
| Accrued expenses                                             |   |           | 3,575      |   |              |   | 3,375 |   |
| Advances payable - officer                                   |   |           | 6,934      |   |              |   | 6,934 |   |
| Notes payable - stockholders                                 |   |           | 198,266    |   |              |   | 198,266 |   |
| Accrued interest - stockholders                              |   |           | 110,290    |   |              |   | 106,336 |   |
| Total current liabilities                                    |   |           | 321,797    |   |              |   | 318,815 |   |
|                                                         |   |           |       |   |              |   |   |   |
| Commitments and contingencies (Notes 1, 2, 3, and 5)         |   |           |       |   |              |   |   |   |
|                                                         |   |           |       |   |              |   |   |   |
| Stockholders' (deficit):                                     |   |           |       |   |              |   |   |   |
| Preferred stock - no par value, authorized 1,000,000 shares: |   |           |       |   |              |   |   |   |
| No shares issued or outstanding                              |   |           | -          |   |              |   | - |   |
| Common stock - no par value, 100,000,000 shares authorized:  |   |           |       |   |              |   |   |   |
| 14,425,903 shares issued and outstanding                     |   |           | 6,903,766  |   |              |   | 6,903,766 |   |
| Additional paid-in capital                                   |   |           | 238,866    |   |              |   | 235,873 |   |
| Accumulated deficit through October 11, 2006                 |   |           | (7,302,235 | )      |              |   | (7,302,235 | ) |
| (Accumulated deficit) during development stage               |   |           | (162,193   | )      |              |   | (156,219 | ) |
| Total stockholders' (deficit)                                |   |           | (321,797   | )      |              |   | (318,815 | ) |
|                                                         |   |           |       |   |              |   |   |   |
| Total liabilities and stockholders' (deficit)                |   | $              | 0          |   |              | $      | 0.00 |   |

----

|                                 |   |        |       |   |        |   |       | Development Period |   |
|--------------------------------------|--------|--------|------------|--------|--------|--------|------------|--------------------|--------|
|                                 |   |        |       |   |        |   |       | October 11, 2006   |   |
|                                 |   | 2016   |       |   | 2015   |   |       | to Mar 31, 2016    |   |
|                                 |   |        |       |   |        |   |       |                    |   |
|                                 |   |        |       |   |        |   |       |                    |   |
| Revenues                             |   | $      | -          |   |   | $      | -          |               |   | $ | - |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Expenses:                            |   |   |       |   |   |   |       |               |   |   |   |   |
| General and administrative:          |   |   |       |   |   |   |       |               |   |   | - |   |
| Financing costs                      |   |   | -          |   |   |   | -          |               |   |   | 2,917 |   |
| Consulting fees                      |   |   | -          |   |   |   | -          |               |   |   | 8,029 |   |
| Accounting and legal                 |   |   | 525        |   |   |   | 450        |               |   |   | 128,073 |   |
| Investor relations                   |   |   | 1,295      |   |   |   | 411        |               |   |   | 42,341 |   |
| Total expenses                       |   |   | 1,820      |   |   |   | 861        |               |   |   | 181,360 |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Operating (loss)                     |   |   | (1,820     | )      |   |   | (861       | )                  |   |   | (181,360 | ) |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Other income (expense):              |   |   |       |   |   |   |       |               |   |   |   |   |
| Gain from litigation settlement      |   |   | -          |   |   |   | -          |               |   |   | 137,310 |   |
| Interest (expense)                   |   |   | (3,954     | )      |   |   | (3,911     | )                  |   |   | (110,290 | ) |
|                                 |   |   | (3,954     | )      |   |   | (3,911     | )                  |   |   | 27,020 |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Income (loss) before income taxes    |   |   | (5,774     | )      |   |   | (4,772     | )                  |   |   | (154,340 | ) |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Provision for income taxes           |   |   | 200        |   |   |   | 200        |               |   |   | 7,990 |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Net income (loss)                    |   | $      | (5,974     | )      |   | $      | (4,972     | )                  |   | $ | (162,330 | ) |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Net (loss) per common share:         |   |   |       |   |   |   |       |               |   |   |   |   |
| Basic and Diluted                    |   | $      | Nil        |   |   | $      | Nil   |               |   | $ | Nil  |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Weighted average shares outstanding: |   |   |       |   |   |   |       |               |   |
| Basic and Diluted                    |   |   | 14,425,903 |   |   |   | 14,425,903 |               |   |   |   |   |

----

|                                                   |   |        |   |   |        |   |   |                    |   |
|--------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------------------|--------|
|                                                   |   |        |   |   |        |   |   | Development Period |   |
|                                                   |   |        |   |   |        |   |   | October 11, 2006   |   |
|                                                   |   | 2016   |   |   | 2015   |   |   | to March 31, 2016  |   |
|                                                   |   |        |   |   |        |   |   |                    |   |
|  Cash flows from operating activities:            |   |        |   |   |        |   |   |                    |   |
|  Net income (loss)                                |   | $      | (5,974 | )      |   | $      | (4,971 | )                  |   | $ | (133,004 | ) |
| Adjustments to reconcile net income (loss) to net cash |   |   |   |   |   |   |   |               |   |
|  used by operating activities:                    |   |   |   |   |   |   |   |               |   |   |   |   |
|  Gain from litigation settlement                  |   |   |   |   |   |   |   |               |   |   | (137,310 | ) |
|  Shares issued for loan fees and consulting fees  |   |   |   |   |   |   |   | 10,946             |   |
| Changes in operating assets and liabilities:           |   |   |   |   |   |   |   |               |   |
|  Accounts payable                                 |   |   | (1,172 | )      |   |   | 860    |               |   |   | (6,268 | ) |
|  Accrued expenses                                 |   |   | 200    |   |   |   | 200    |               |   |   | 3,100 |   |
|  Judgement payable                                |   |   |   |   |   |   |   |               |   |   | (27,750 | ) |
|  Accrued interest                                 |   |   | 3,954  |   |   |   | 3,911  |               |   |   | 91,589 |   |
|  Total adjustments                                |   |   | 2,982  |   |   |   | 4,971  |               |   |   | (65,693 | ) |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |
| Net cash (used in) operating activities                |   |   | (2,992 | )      |   |   | -      |               |   |   | (198,697 | ) |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |
|  Cash flows from investing activities:            |   |   |   |   |   |   |   |               |   |   |   |   |
| Net cash (used in) investing activities                |   |   | -      |   |   |   | -      |               |   |   | - |   |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |
| Cash flows from financing activities:                  |   |   |   |   |   |   |   |               |   |   |   |   |
| Proceeds from notes payable - stockholders             |   |   |   | 11,270 |   |   |   | 182,898            |   |
| Cash Proceeds from add'l Paid in Capital               |   |   | 2,992  |   |   |   |   |               |   |   | 8,865 |   |
| Advances from officer                                  |   |   |   |   |   |   |   |               |   |   | 6,934 |   |
| Net cash provided by financing activities              |   |   | 2,992  |   |   |   | 11,270 |               |   |   | 198,697 |   |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |
| Net increase in cash and equivalents                   |   |   | -      |   |   |   | 11,270 |               |   |   | - |   |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |
| Cash and equivalents at beginning of year              |   |   | -      |   |   |   | -      |               |   |   | - |   |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |
| Cash and equivalents at end of year                    |   | $      | -      |   |   | $      | -      |               |   | $ | - |   |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |
| Supplemental Cash Flow Information                     |   |   |   |   |   |   |   |               |   |   |   |   |
| Interest paid                                          |   | $      | -      |   |   | $      | -      |               |   | $ | - |   |
| Income taxes paid                                      |   | $      | -      |   |   | $      | -      |               |   | $ | 7,670 |   |

----

----

----

----

| Period Ending           |   | Estimated NOL Carry-forward |   | NOL Expires |   | Estimated Tax Benefit from NOL |   | Valuation Allowance |   | Change in Valuation Allowance | Net Tax Benefit |
|-------------------------|--------|-----------------------------|--------|-------------|--------|--------------------------------|--------|---------------------|--------|-------------------------------|-----------------|
| March 31, 2016          |   | $ 2,000                     |   | Various     |   | 400                            |   | (400)               |   | $(-0-)                        | $—        |
|  December 31, 2015 |   | 590,000                     |   | Various     |   | 133,000                        |   | (133,000)           |   | $(-0-)                        | $—        |

----

| Federal tax expense (benefit) at statutory rate |   |   | (15.00 | %) |
|-------------------------------------------------|--------|--------|--------|----|
| State tax expense (benefit), net of federal tax |   |   | (7.65  | %) |
| Deferred income tax valuation allowance         |   |   | 22.65  | %  |
| Reported tax rate                               |   |   | 0      | %  |

----

----

|  | · | The worldwide economic situation; |
|--|--------|-----------------------------------|

|  | · | Any change in interest rates or inflation; |
|--|--------|--------------------------------------------|

|  | · | The willingness and ability of third parties to honor their contractual commitments; |
|--|--------|--------------------------------------------------------------------------------------|

|  | · | Our ability to raise additional capital, as it may be affected by current conditions in the stock market and competition for risk capital; |
|--|--------|--------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | Environmental and other regulations, as the same presently exist and may hereafter be amended. |
|--|--------|------------------------------------------------------------------------------------------------|

----

|  | 31.1 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Borivoje Vukadinovic. |
|--|------|---------------------------------------------------------------------------------------------------|

|  | 32.1 | Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Borivoje Vukadinovic. |
|--|------|---------------------------------------------------------------------------------------------------|

|  | 101 | Interactive Data Files *To be filed by amendment |
|--|-----|--------------------------------------------------|

----

|                     | RETROSPETTIVA, INC |                                                                                 |
|--------------------------|--------------------|--------------------------------------------------------------------------------------|
|                     |               |                                                                                 |   |
| Date:  May 13, 2016 | By:                | /s/ Borivoje Vukadinovic                                                        |   |
|                     |               | Borivoje Vukadinovic, Director, Chief Executive Officer, and Chief Financial Officer |   |
|                     |               |                                                                                      |   |
|                     |               |                                                                                 |   |